Eversept Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
19,308
-106,588
-85% -$5.76M 0.07% 100
2026
Q1
$6.58M Sell
125,896
-251,509
-67% -$15.1M 0.35% 55
2025
Q4
$22.2M Sell
377,405
-214,135
-36% -$13M 1.12% 22
2025
Q3
$32.9M Buy
591,540
+197,401
+50% +$10.6M 2.27% 16
2025
Q2
$20.3M Buy
394,139
+114,022
+41% +$5.73M 1.87% 16
2025
Q1
$16.4M Sell
280,117
-19,193
-6% -$1.3M 1.67% 21
2024
Q4
$21.6M Sell
299,310
-364,263
-55% -$26.7M 1.91% 12
2024
Q3
$53M Buy
663,573
+120,529
+22% +$9.06M 3.63% 11
2024
Q2
$38.9M Sell
543,044
-64,643
-11% -$4.76M 2.66% 12
2024
Q1
$42.8M Buy
607,687
+142,380
+31% +$10.2M 2.85% 10
2023
Q4
$35.9M Buy
465,307
+79,418
+21% +$5.23M 3.15% 9
2023
Q3
$26.3M Buy
385,889
+43,252
+13% +$3.42M 2.22% 10
2023
Q2
$28M Buy
342,637
+153,978
+82% +$12.4M 2.34% 10
2023
Q1
$14M Buy
188,659
+172,024
+1,034% +$13.3M 0.98% 22
2022
Q4
$1.38M Buy
+16,635
New +$1.32M 0.12% 54
2022
Q2
Sell
-4,248
Closed -$460K 98
2022
Q1
$460K Buy
+4,248
New +$438K 0.04% 78

Other funds holding TECH

Eversept Partners's TECH Position: Q2 2026 in Review

Eversept Partners reduced its Bio-Techne (TECH) stake by 85% in Q2 2026, selling an estimated $5.76M and leaving 19,308 shares worth $1.36M. The position accounts for 0.07% of the portfolio, ranked #100.

Eversept Partners first reported a position in TECH in Q1 2022 and has held it in 16 quarters since. The position peaked at $53M in Q3 2024. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Eversept Partners held 19,308 shares of Bio-Techne worth $1.36M as of Q2 2026.
  • Eversept Partners sold 106,588 Bio-Techne shares in Q2 2026, an estimated $5.76M.
  • Bio-Techne made up 0.07% of Eversept Partners's portfolio in Q2 2026, its #100 holding.
  • Eversept Partners first reported a position in Bio-Techne in Q1 2022 and has held it in 16 quarters since.
  • Eversept Partners's Bio-Techne position peaked at $53M in Q3 2024.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.